GlaxoSmithKline PLC
9 January 2001
Directors' Interests
I give below details of changes in directors' interests in the Ordinary Shares
of GlaxoSmithKline plc:
The following non-executive directors of the Company were provisionally
allocated the following ordinary shares under the SmithKline Beecham plc share
election arrangements for non-executive directors:
Non-Executive Directors Deferred Retainer Fees
Non-Executive Director No. of Shares Average Price (£) Allocation Date
Sir Peter Walters 329.699 18.957 2nd January 2001
Dr L Shapiro 117.776 18.957 2nd January 2001
Mr J Young 124.913 18.957 2nd January 2001
Non-Executive Directors Share Allocation (Ordinary Shares) - Annual Dividend
Reinvestment
Non-Executive Director No. of Shares Average Price (£) Allocation Date
Sir Peter Walters 87.612 18.957 31st December 2000
Sir Christopher Hogg 6.33 18.957 31st December 2000
Baroness Hooper 6.33 18.957 31st December 2000
Sir Ian Prosser 6.33 18.957 31st December 2000
Dr L Shapiro 17.038 18.957 31st December 2000
Mr J Young 60.071 18.957 31st December 2000
Non-Executive Directors Share Allocation (ADR's) - Annual Dividend
Reinvestment
Non-Executive Director No. of ADRs Average Price ($) Allocation Date
Mr P Allaire 3.31 56.0625 31st December 2000
Mr D McHenry 3.31 56.0625 31st December 2000
Dr L Shapiro 3.31 56.0625 31st December 2000
Mr J Young 3.31 56.0625 31st December 2000
The Company was notified of this information on 3rd January 2001.
S M Bicknell
Company Secretary
9th January 2001
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.